As expected, the data of luciferase reporter gene and ChIP assays revealed that NF‐κB could bind to the promoter region of NKILA, thereby activating its transcriptional activity and promoting NKILA expression in laryngeal cancer cell lines. Here, NFKB1 is linked to laryngeal carcinoma.